GE HealthCare Technologies (GEHC) EV to EBIT (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported EV to EBIT for 5 consecutive years, with 36.58 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBIT fell 20.97% year-over-year to 36.58; the trailing twelve-month figure through Jun 2026 stood at 9.89 (down 9.85% YoY), and the FY2025 full-year result was 11.97, down 4.91% from the prior year.
• EV to EBIT eased to 36.58 in Q2 2026 per GEHC's latest filing, from 58.85 in the prior quarter.
• Across five years, EV to EBIT topped out at 72.4 in Q1 2024 and bottomed at 32.53 in Q4 2022.
• Historically, EV to EBIT has averaged 50.83 across 5 years, with a median of 47.7 in 2023.
• The sharpest annual moves came in 2023 and 2025: EV to EBIT soared 46.62% in 2023, then fell 23.82% in 2025.
• Over 5 years, EV to EBIT stood at 32.53 in 2022, then surged by 46.62% to 47.7 in 2023, then slipped by 13.51% to 41.26 in 2024, then fell by 3.06% to 39.99 in 2025, then retreated by 8.53% to 36.58 in 2026.
• According to Business Quant data, EV to EBIT over the past three periods registered 36.58, 58.85, and 39.99 for Q2 2026, Q1 2026, and Q4 2025 respectively.